Invention Grant
- Patent Title: Tuberculosis vaccine with improved efficacy
- Patent Title (中): 结核病疫苗具有改善的疗效
-
Application No.: US13165904Application Date: 2011-06-22
-
Publication No.: US08545854B2Publication Date: 2013-10-01
- Inventor: Leander Grode , Stefan H. E. Kaufmann , Baerbel Raupach , Juergen Hess
- Applicant: Leander Grode , Stefan H. E. Kaufmann , Baerbel Raupach , Juergen Hess
- Applicant Address: DE Munich
- Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenshaften, e.V.
- Current Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenshaften, e.V.
- Current Assignee Address: DE Munich
- Agency: Rothwell, Figg, Ernst & Manbeck, P.C.
- Main IPC: A61K39/04
- IPC: A61K39/04 ; A61K49/00 ; C07H21/04
Abstract:
The present invention relates to novel recombinant vaccines providing protective immunity against tuberculosis. Further, the present invention refers to novel recombinant nucleic acid molecules, vectors containing said nucleic acid molecules, cells transformed with said nucleic acid molecules and polypeptides encoded by said nucleic acid molecules.
Public/Granted literature
- US20120027794A1 TUBERCULOSIS VACCINE WITH IMPROVED EFFICACY Public/Granted day:2012-02-02
Information query
